Menu
Recruiting NCT06989593

Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions

No phase Interventional DSD Hypospadias

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Narrative Medicine Journaling Intervention.
Who it may be relevant to
Registry conditions: DSD, Hypospadias. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to learn whether a journaling intervention can reduce stress and anxiety in parents of children with urogenital conditions (such as differences of sex development and hypospadias). The main questions it aims to answer are: * Does guided journaling help to reduce anxiety levels in parents of children with urogenital conditions? * What are parents' perspectives on group-based writing interventions for future support programs? Participants will: * Complete a short anxiety questionnaire (the General Anxiety Disorder-7 scale) at the beginning of the study * Receive a physical journal with 5 writing prompts designed to help process emotions related to their child's condition * Complete 5 journal entries over several weeks, writing about their experiences and feelings * Complete the same anxiety questionnaire again after finishing the journal entries * Participate in a 45-minute interview to discuss how the journaling affected their stress levels and gather feedback on potential group-based writing programs

Interventions

  • Behavioral Narrative Medicine Journaling Intervention
    Participants will complete the GAD-7 anxiety assessment at baseline. They will then receive a physical journal containing 5 structured, therapeutic writing prompts designed to help process emotions related to their child's diagnosis. Prompts focus on processing experiences with diagnosis, addressing uncertainty, coping with stigma, and developing resilience. Parents will be instructed to complete the 5 journal entries, spending 15-20 minutes on each writing session at least once per week. Follow

Primary outcome measures

  • Change in GAD-7 Anxiety Scores [Time frame: Change from baseline (pre-intervention) to approximately 6 weeks post-intervention initiation]
Secondary outcome measures (4)
  • Qualitative Assessment of Anxiety Related to Child's Diagnosis [Time frame: Measured at one follow-up interview, approximately 6 weeks after intervention initiation]
  • Changes in Parental Coping Strategies [Time frame: Measured at one follow-up interview, approximately 6 weeks after intervention initiation]
  • Interest in Group-Based Writing Interventions [Time frame: Approximately 6 weeks after intervention initiation]
  • Feasibility and Acceptability of Journaling Intervention [Time frame: Approximately 6 weeks after intervention initiation]

Eligibility criteria

Inclusion criteria

  • Parent or legal guardian of a child (age 0-17 years) diagnosed with a urogenital condition (such as differences of sex development or hypospadias)
  • Able to read and understand English
  • Willing to complete a guided journaling intervention (through writing or dictation) over a period of approximately 5 weeks
  • Willing to participate in a 45 minute follow-up interview
  • Able to provide informed consent

Exclusion criteria

  • Parent/guardian with severe psychiatric disorder that would interfere with participation as determined by referring physician
  • Parent/guardian unable to complete either written journaling activities or dictation
  • Inability to provide informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Boston Children's Hospital — Boston

Identifiers

NCT: NCT06989593 · IRB-P00051291 · 89676

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗